Furlow Brenda S. 4

Accession 0001437749-22-020845

CIK 0000842023other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:22 PM ET

Size

26.5 KB

Accession

0001437749-22-020845

Form 4

Period: 2022-08-15

SVP - General Counsel

Transactions

Award
Restricted Stock Units
2022-08-15+1,984→ 1,984 total
→ Common Stock (1,984 underlying)
Award
Stock Options (Right to Buy)
2022-08-15+6,166→ 6,166 total
Exercise: $378.08Exp: 2029-08-15→ Common Stock (6,166 underlying)

Holdings

Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (7,492 underlying)
7,492
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying)
8,325
Stock Options (Right to Buy)
Exercise: $481.82Exp: 2028-08-06→ Common Stock (6,080 underlying)
6,080
Common Stock
6,523
Common Stock
(indirect: By Trust)
1,330
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying)
8,325
Restricted Stock Units
→ Common Stock (1,167 underlying)
1,167
Stock Options (Right to Buy)
Exercise: $190.41Exp: 2026-08-07→ Common Stock (9,968 underlying)
9,968
Restricted Stock Units
→ Common Stock (1,679 underlying)
1,679
Stock Options (Right to Buy)
Exercise: $481.82Exp: 2028-08-06→ Common Stock (4,560 underlying)
4,560
Common Stock
(indirect: By Trust)
1,330
Stock Options (Right to Buy)
Exercise: $177.32Exp: 2025-08-08→ Common Stock (16,562 underlying)
16,562
Stock Options (Right to Buy)
Exercise: $190.41Exp: 2026-08-07→ Common Stock (13,290 underlying)
13,290
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (9,990 underlying)
9,990
Stock Options (Right to Buy)
Exercise: $372.44From: 2022-08-31Exp: 2028-03-01→ Common Stock (10,997 underlying)
10,997
Stock Options (Right to Buy)
Exercise: $125.05Exp: 2024-08-09→ Common Stock (9,503 underlying)
9,503

Footnotes (12)

[F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F10]Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
[F11]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F12]Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
[F2]Options to purchase 1,542 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 1,541 shares vest on 8/15/2024 and 8/15/2026.
[F3]661 shares vest on each of 8/15/2023 and 8/15/2025, and 662 shares vest on 8/15/2024.
[F4]Fully exercisable.
[F5]On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
[F6]Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
[F7]Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F8]Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
[F9]Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother